A Study of Melatonin Concentration During Lactation

Description

This research is being done to understand better how a mother's emotional well-being and lifestyle, such as her levels of stress, fatigue, depression, anxiety, sleep quality, and eating habits, might affect the levels of melatonin and sIgA in her breast milk.

Conditions

Breastfeeding

Study Overview

Study Details

Study overview

This research is being done to understand better how a mother's emotional well-being and lifestyle, such as her levels of stress, fatigue, depression, anxiety, sleep quality, and eating habits, might affect the levels of melatonin and sIgA in her breast milk.

Melatonin and Secretory Immunoglobulin A (sIgA) Concentration During Lactation, Maternal Determinants and Repercussions

A Study of Melatonin Concentration During Lactation

Condition
Breastfeeding
Intervention / Treatment

-

Contacts and Locations

Eau Claire

Mayo Clinic Health System - Eau Claire, Eau Claire, Wisconsin, United States, 54703

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Possess a refrigerator with a freezer or a standalone freezer for sample storage at home.
  • * Ability to be contacted by telephone.
  • * Having internet access at home.
  • * Being in the immediate (0-14 days) postpartum period.
  • * Currently breastfeeding or planning to breastfeed, regardless of the type.
  • * Newborns with congenital malformations.
  • * Newborns with birth weights less than 2,500g or greater than 4,000g.
  • * Gestational age less than 37 completed weeks or greater than 42 completed weeks.
  • * Mothers hospitalized in an intensive care unit (ICU).
  • * Newborns hospitalized in the neonatal intensive care unit (NICU) or special care nursery (SCN).
  • * Mothers using sleep aids (e.g., Benadryl, Unisom, Melatonin, Valerian).
  • * Mothers currently being treated for pharmacologically treated mood and sleep disorders.
  • * Mothers with acute infections longer than 7 days postpartum. Mothers will be withdrawn from study if antibiotics are taken between 7 and 14 days postpartum.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Mayo Clinic,

Ganesh Namachivayam, MD, MPH, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2024-11-30